Home AEC Amgen Doubles Down on US Innovation with $600MM Facility in Thousand Oaks
AECIndustry NewsLife ScienceLos Angeles

Amgen Doubles Down on US Innovation with $600MM Facility in Thousand Oaks

Share
testalize-me-9xHsWmh3m_4-unsplash
Photo by Testalize.me on Unsplash
Share

Amgen Inc. is betting big on the future of American biotechnology with an announcement of plans to invest more than $600 million in a cutting-edge science and innovation center at its Thousand Oaks headquarters. The facility represents the latest move in the pharmaceutical giant's aggressive domestic expansion strategy, which has seen the company pour billions […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Featured Content


Recent Posts

Related Articles

Global Mutual’s Botsford Global Partners Buys Acacia’s 77-Unit Legacy at Westglen in Glendale, Assuming $18.8MM Fannie Mae Loan

Global Mutual's fledgling Botsford Global Partners platform has closed on Acacia Capital's...

The Registry Ranks: SoCal’s Best Lab Submarkets for a Biotech Signing a Lease Right Now

San Diego lab vacancy just hit a new cycle high and Los...